drug candidates

Samsung Electronics Co., South Korea’s tech behemoth, has put forward global research on 6G service frequencies as it aims to take the lead in...

HK inno.N is expediting its global expansion with its latest drug K-Cab designed to treat peptic ulcers.The South Korean pharmaceutical company an...

South Korea’s Hanmi Pharmaceutical Co. generated sales of more than 1 trillion won ($812.3 million) from its own medicines last year on strong...

South Korea’s SK Chemicals plans to invest more than 2 trillion won ($1.6 billion) in eco-friendly material and biopharmaceutical businesses.T...

South Korea’s Hanmi Pharmaceutical Co. is set to launch its blockbuster high blood pressure drug Amosartan in China, the world’s largest...

South Korea’s biotechnology startup Voronoi Inc. is in talks with global biomedical companies on drug designs as it aims to expand the busines...

South Korea's biotech startup Novelty Nobility Inc. has signed a global license agreement for its antibody treatment candidate with a US biopharmace...

Viva Republica Inc., the operator of fintech platform Toss, is revving up for a pre-IPO. When finalized, the company will become South Korea’s...

Ahead of the 20th presidential election slated for March 9, candidates from both parties have vowed to legislate and systemize digital assets if ele...

Kolon TissueGene Inc., the cell therapies unit of South Korean pharmaceutical company Kolon Life Science Inc., said on Dec. 28 it has resumed admi...

South Korea’s HK inno.N Corp. has signed a 640 billion won ($540 million) contract to license out its technology for K-CAB, a gastroesophageal...

MedPacto Inc., a South Korean biotechnology company that develops therapeutics for cancer and autoimmune diseases, has agreed with global drugmaker ...

South Korea’s Celltrion Inc. has long been a biosimilar player, producing replicas of original drugs, a growing market in the pandemic era.Ear...

Singapore's sovereign wealth fund GIC, Sweden-based EQT Partners and South Korea-based MBK Partners are among the four shortlisted bidders for share...

The global semiconductor industry is keeping a close eye on whether Taylor, a city located in Williamson County of Texas and the most probable site ...

Samsung Bioepis Co., a leading South Korean biopharmaceutical company, has received approval from the US Food and Drug Administration for its Byoovi...

A number of new rare disease treatments, approved in South Korea over the past year, are still unaffordable for the public because of their price ta...

South Korea’s pharmaceutical company Medytox Inc. has ended a botulinum toxin-related technology transfer contract with AbbVie, clouding its b...

LX Hausys Ltd., South Korea's leading building materials maker, on Monday announced a plan to join Seoul-based IMM Private Equity in acquiring a con...

South Korea’s Samsung Biologics Co. is gearing up for the drug substance (DS) sector of the messenger ribonucleic acid (mRNA)-based COVID-19 v...

South Korea’s online retail platform Interpark Corp. has failed to drum up interest from the country's largest online platforms, including Nav...

SK E&S Co., the largest city gas supplier in South Korea, has shortlisted four candidates among seven preliminary bidders to invest in 2 trillio...

South Korea-based Daewoong Pharmaceutical Co. is hoping to achieve 5 trillion won ($4.4 billion) in sales by 2027, meaning that the company aims to ...

South Korea's entertainment- and food-focused CJ Group has emerged as a darkhorse to buy a controlling stake worth about 300 billion won ($260 milli...

The rise of the platform economy is a global phenomenon. The spread of the coronavirus pandemic has accelerated the use of contactless technology an...

South Korea’s SK Biopharmaceuticals Co. said on Friday it aspires to become one of the world’s top 10 healthcare companies by 2030 with ...

Eyegene Inc. will be South Korea’s first vaccine maker to conduct clinical tests of messenger ribonucleic acid (mRNA) COVID-19 vaccines. Ealie...

Delivery Hero SE on Thursday postponed the deadline again for the final bidding of South Korea's Yogiyo, amid market doubts over the country's No. 2...

South Korea’s M&A market is heating up as the outlook for the global economic recovery is becoming more comfortable this year.The M&A ...

South Korean biosimilar maker Celltrion Inc. and Mirae Asset Group have agreed to an investment that will render them the top shareholder in Iksuda ...